Package 33342-091-12

{"route": ["ORAL"], "spl_id": "3ac90f1e-d2a5-4645-972b-0d627e4cc860", "openfda": {"upc": ["0333342089090", "0333342091093", "0333342090096"], "unii": ["9IY2357JPE"], "rxcui": ["312835", "312836", "314214", "314215"], "spl_set_id": ["4364f6ef-a8da-4805-be0d-aabbe8ca2d21"], "manufacturer_name": ["Macleods Pharmaceuticals Limited"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "3 BLISTER PACK in 1 BOX, UNIT-DOSE (33342-091-06)  / 10 CAPSULE in 1 BLISTER PACK", "package_ndc": "33342-091-06", "marketing_start_date": "20140902"}, {"sample": false, "description": "60 CAPSULE in 1 BOTTLE (33342-091-09)", "package_ndc": "33342-091-09", "marketing_start_date": "20140902"}, {"sample": false, "description": "10 BLISTER PACK in 1 BOX, UNIT-DOSE (33342-091-12)  / 10 CAPSULE in 1 BLISTER PACK", "package_ndc": "33342-091-12", "marketing_start_date": "20140902"}, {"sample": false, "description": "500 CAPSULE in 1 BOTTLE (33342-091-15)", "package_ndc": "33342-091-15", "marketing_start_date": "20140902"}], "brand_name": "RIVASTIGMINE TARTRATE", "product_id": "33342-091_3ac90f1e-d2a5-4645-972b-0d627e4cc860", "dosage_form": "CAPSULE", "pharm_class": ["Cholinesterase Inhibitor [EPC]", "Cholinesterase Inhibitors [MoA]"], "product_ndc": "33342-091", "generic_name": "RIVASTIGMINE TARTRATE", "labeler_name": "Macleods Pharmaceuticals Limited", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "RIVASTIGMINE TARTRATE", "active_ingredients": [{"name": "RIVASTIGMINE TARTRATE", "strength": "4.5 mg/1"}], "application_number": "ANDA203148", "marketing_category": "ANDA", "marketing_start_date": "20140902", "listing_expiration_date": "20261231"}